Search

Your search keyword '"Natasha E Holmes"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Natasha E Holmes" Remove constraint Author: "Natasha E Holmes" Topic internal medicine Remove constraint Topic: internal medicine
31 results on '"Natasha E Holmes"'

Search Results

1. Penicillin Allergy Delabeling Program: an exploratory economic evaluation in the Australian context

2. No fever, no worries? A retrospective audit of bacteraemic patients in the emergency department

3. Subsegmental pulmonary embolism and anticoagulant therapy: the impact of clinical context

4. Clinical manifestations of invasive meningococcal disease in Victoria with the emergence of serogroup W and serogroup Y Neisseria meningitidis

5. Risk factors for readmission following inpatient management of <scp>COVID</scp> ‐19 in a low‐prevalence setting

6. Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study

7. The comparative epidemiology and outcomes of hospitalized patients treated with SGLT2 or DPP4 inhibitors

8. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

9. The Use of Procalcitonin as an Antimicrobial Stewardship Tool and a Predictor of Disease Severity in COVID-19

10. Complete recovery from COVID-19 of a kidney-pancreas transplant recipient: potential benefit from everolimus?

11. Matched Case-Control Study of the Long-Term Impact of Beta-Lactam Antibiotic Allergy Testing

12. Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection

13. Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data

14. COVID-MATCH65 – A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2

15. Development and Validation of a Penicillin Allergy Clinical Decision Rule

16. Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study

17. Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia

18. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial

19. Long-term impacts of antibiotic allergy testing on patient perceptions and antibiotic utilization

20. High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukaemia - lessons for immunopathogenesis and prescribing

22. The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study

23. 412. Host Response Biomarkers Predict Clinical Failure in Patients with Staphylococcus aureus Bacteremia (SAB) Treated with Flucloxacillin (FLU) or Vancomycin (VAN)

24. Non-O1, non-O139Vibrio choleraebacteraemia in an Australian population

25. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia

26. Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia

27. Vancomycin therapeutics and monitoring: a contemporary approach

28. Prediction Model to Identify Patients at Risk of 30-Day Treatment Failure in Patients With Staphylococcus aureus Bacteremia

29. Combination Therapy Did Not Reduce 30-Day Treatment Failure in Patients With Staphylococcus aureus Bacteremia (SAB)

30. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations

31. Report of oral clarithromycin desensitization

Catalog

Books, media, physical & digital resources